Sort
48,018 grants matching “immunotherapy”
Regulation of the STING pathway under sterile conditions
$390,000Sonal Srikanth · University Of California Los Angeles · R01 · FY2021 · AI
B Cells in Transplantation Tolerance
$390,000Anita S. Chong · University Of Chicago · R01 · FY2010 · AI
Controlled Release of Macromolecules
$390,000Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2017 · EB
Osteomucosal healing and immunity in medication-related osteonecrosis of the jaw
$390,000Reuben Han-Kyu Kim · University Of California Los Angeles · R56 · FY2023 · DE
B Cells in Transplantation Tolerance
$390,000Anita S. Chong · University Of Chicago · R01 · FY2009 · AI
Controlled Release of Macromolecules
$390,000Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2016 · EB
Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationships
$390,000Xinshu Grace Xiao · University Of California Los Angeles · R01 · FY2022 · CA
UNC Food Allergy Initiative
$390,000Edwin Kim · Univ Of North Carolina Chapel Hill · U01 · FY2024 · AI
Regulation of the STING pathway under sterile conditions
$390,000Sonal Srikanth · University Of California Los Angeles · R01 · FY2020 · AI
UNC Food Allergy Initiative
$390,000Edwin Kim · Univ Of North Carolina Chapel Hill · U01 · FY2025 · AI
Regulation of the STING pathway under sterile conditions
$390,000Sonal Srikanth · University Of California Los Angeles · R01 · FY2022 · AI
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses
$389,857John M. Wrangle · Medical University Of South Carolina · R01 · FY2023 · CA
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses
$389,857John M. Wrangle · Medical University Of South Carolina · R01 · FY2022 · CA
Leveraging Zika virus and the immune system to treat glioblastoma
$389,854Milan Girish Chheda · Washington University · R01 · FY2021 · NS
Novel mechanism of chemokine nitration in bladder cancer
$389,848Neelam Mukherjee · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Targeting the colchicine binding site in tubulin for cancer therapy
$389,817Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2023 · CA
Targeting the colchicine binding site in tubulin for cancer therapy
$389,817Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA
Initiation of Immune Response in Chronic Leishmaniasis
$389,813Phillip A. Scott · University Of Pennsylvania · R01 · FY2010 · AI
Role of Integrins in Natural Killer Cell Function
$389,782Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
$389,775Paul E Kinahan · University Of Washington · U24 · FY2023 · CA
Mechanistic difference of NF-kappaB in lung physiology and tumorigenesis
$389,761Gutian Xiao · University Of Southern California · R01 · FY2022 · CA
Mechanistic difference of NF-kappaB in lung physiology and tumorigenesis
$389,761Zhaoxia Qu · University Of Southern California · R01 · FY2025 · CA
Arginase positive monocyte mediated RGC neuroprotection after traumatic optic neuropathy
$389,739Andrew Robert Sas · Ohio State University · R01 · FY2025 · EY
Project 5: Enhancement of the Anti-Tumor Activity and Targeted Applications of Third Party Donor-Derived EBV-specific T-cells
$389,736Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA
Mechanisms of Arginine Deprivation in Small Cell Lung Cancer
$389,699Trudy Gale Oliver · Duke University · R01 · FY2025 · CA